US2015352752A1PendingUtilityA1
An aqueous -solvent based process for continuous manufacturing of supported ion selective membranes
Est. expiryJan 16, 2033(~6.4 yrs left)· nominal 20-yr term from priority
B29K 2263/00B29C 39/14C08J 5/22B29L 2031/755
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A membrane, for example an ion exchange membrane, is made by preparing a curable liquid using at least one aqueous solvent. The curable liquid is continuously cast onto a substrate to form a membrane precursor. The membrane precursor is continuously cured to form a membrane. Optionally, the curable liquid may be made by mixing a water soluble aliphatic sulfonic acid monomer with a pair of crosslinking monomers and a water soluble free-radical generating catalyst. Optionally, the method may include one or more steps of processing the membrane.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for manufacturing a membrane, the method comprising:
a. preparing a curable liquid with an aqueous solvent; b. casting a membrane precursor; and c. curing the membrane precursor to form a membrane, wherein the step (b) comprises introducing the curable liquid into a film pocket and wetting a substrate, and wherein the steps (b) and (c) operate continuously.
2 . The method of claim 1 , wherein the step (a) comprises mixing a water soluble aliphatic sulfonic acid monomer with a pair of crosslinking monomers and a water soluble free-radical generating catalyst.
3 . The method of claim 2 , wherein the water soluble, aliphatic sulfonic acid monomer is selected from a group consisting of 2-acrylamido-2-methylpropane sulfonic acid, sulfoethyl methacrylate, and sulfopropyl methacrylate.
4 . The method of claim 2 , wherein the pair of crosslinking monomers are selected from the group consisting of acrylamide paired with N-methylolacrylamide and methacrylamide paired with N-methylolmethacrylamide.
5 . The method of claim 1 , wherein the step (a) comprises mixing a solution of a bifunctional methylenebisacrylamide monomer with an ionogenic acrylic monomer and a water soluble, free-radical generating catalyst.
6 . The method of claim 5 , wherein the ionogenic acrylic monomer is selected from a group consisting of compounds with the following formula:
wherein:
R=H, CH 3 ;
R 1 =C 1 -C 22 ;
R 2 , R 3 , R 4 =H, CH 3 , alkyl containing C 2 -C 22 , benzyl, phenyl; and
X − =Cl − ,Br − ,½SO4 − ,NO3 − .
7 . The method of claim 5 , wherein the ionogenic acrylic monomer has the following formula:
8 . The method of claim 1 , wherein the step (a) comprises mixing a water soluble, ionic, cross-linking monomer and a water soluble, free-radical generating catalyst.
9 . The method of claim 8 , wherein the water soluble, ionic, crosslinking monomer is a product of mixing a glycidyl ester, an ionogenic methacrylate ester and a water soluble acid, wherein the ionogenic methacrylate ester comprises a vinyl group and a tertiary amine group and wherein the water soluble, ionic, cross-linking monomer has the following formula:
10 . The method of claim 8 , further comprising adding an ionogenic methacrylate ester monomer to the curable liquid.
11 . The method of claim 1 , wherein the step (a) comprises mixing a tertiary amine, an acid, and a polyepoxide.
12 . The method of claim 11 , wherein the tertiary amine is selected from a group consisting of dimethylaminopropylmethacrylamide, dimethylaminopropyl acrylamide, diethylaminopropylmethacrylamide, dimethylaminoethyl methacrylate, and mixtures thereof.
13 . The method of claim 11 , wherein the polyepoxide is selected from the group consisting of diethylene glycol diglycidyl ether; diglycidyl 1,2-cyclohexanedicarboxylate; N,N-diglycidyl-4-glycidyloxyaniline; bisphenol A diglycidyl ether; brominated bisphenol A diglycidyl ether; bisphenol F diglycidyl ether; 1,4-butanediol diglycidyl ether; 1,4-butanediyl diglycidyl ether; 1,4-cyclohexanedimethanol diglycidyl ether; glycerol diglycidyl ether; resorcinol diglycidyl ether; bis[4-(glycidyloxy)phenyl]methane; bisphenol A propoxylate diglycidyl ether; dimer acid diglycidyl ester; ethylene glycol diglycidyl ether; brominated neopentyl glycol diglycidyl ether; diglycidyl ether-terminated poly(dimethylsiloxane); poly(ethylene glycol)diglycidyl ether; poly(propyleneglycol)diglycidyl ether; 1,2,3-propanetriol glycidyl ether; 1,3-butanediol diglycidyl ether; tris(2,3-epoxypropyl)isocyanurate; trimethylolpropane triglycidyl ether; tris(4-hydroxyphenyl)methane triglycidyl ether 2,6-tolylene diisocyanate; tris(4-hydroxyphenyl)methane triglycidyl ether; glycerol propoxylate triglycidyl ether; trimethylolethane triglycidyl ether; 1,3-butadiene-diepoxide; 1,3-butadiene diepoxide; dicyclopentadiene dioxide; and methyl cis,cis-11,12,14,15-diepoxyeicosanoate.
14 . The method of claim 11 , further comprising adding an ethylenic monomer to the curable liquid.
15 . The method of claim 14 , wherein the ethylenic monomer is selected from a group consisting of methacrylamine; N-methylmethacrylamide; N-vinyl pyrrolidone; N-vinyl caprolactam; methacrylamidopropyl trimethylammonium chloride; and trimethylammoniumethyl methacrylate chloride.
16 . The method of claim 11 , further comprising adding a water soluble, free-radical generating catalyst.
17 . The method of claim 1 , wherein the step (a) comprises mixing a primary crosslinker with a secondary crosslinker, wherein the primary crosslinker comprises a crosslinked ionic monomer that comprises a quaternary ammonium group.
18 . The method of claim 17 , wherein the crosslinked ionic monomer is a product of mixing polyepoxide with a tertiary amine including an acrylic group in the presence of an acid.
19 . The method of claim 17 , wherein the primary crosslinked ionic monomer has the formula:
wherein:
R is —[CH 2 —CH(OH)] 2 —W;
R 1 is hydrogen or a C 1 -C 12 alkyl group;
Z is oxygen or N—R 3 ; R 2 is —[CH 2 ] n —;
R 3 is hydrogen or —[CH 2 ] m —CH 3 ;
R 4 and R 5 are each, independently, —[CH 2 ] m —CH 3 ;
X is selected from the group consisting of Cl, Br, I and acetate;
W is a bridging group or atom;
m is an integer from 0 to 20; and
n is an integer from 1 to 20.
20 . The method of claim 17 , wherein the secondary crosslinker is prepared by mixing an acrylamide compound with another acrylamide compound including hydroxyl groups.
21 . The method of claim 1 , further comprising (d) processing the membrane comprising conveying the membrane through at least two processing areas.
22 . The method of claim 21 , further comprising conveying the membrane precursor from a processing area for step (c) to a processing area for step (d).
23 . The method of claim 22 , further comprising conveying the substrate through processing areas for step (b) to the processing area for step (c).
24 . The method of claim 21 , wherein the step (d) further comprises extracting residues from the membrane and washing the membrane.
25 . The method of claim 24 , wherein, following the steps of extracting the residues from the membrane and washing the membrane, step (d) further comprises:
applying a dye to a first surface of the membrane; feeding a contrast material adjacent a second surface of the membrane; identifying dye marked regions of the contrast material; and cutting the membrane.
26 . The method of claim 1 , wherein the aqueous solvent comprises water.Join the waitlist — get patent alerts
Track US2015352752A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.